Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Gertsch TimothyOwnership Type:Direct OwnershipSecurities:Options (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:69,189Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Gertsch TimothyOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:42,041Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Venkatachaliah GirishOwnership Type:Direct OwnershipSecurities:Options (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:184,502Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Venkatachaliah GirishOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:112,108Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Shaker BenjaminOwnership Type:Direct OwnershipSecurities:Options (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:322,879Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Shaker BenjaminOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:196,189Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Desai VeeralOwnership Type:Direct OwnershipSecurities:Options (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:322,879Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Desai VeeralOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:196,189Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Sell StevenOwnership Type:Direct OwnershipSecurities:Options (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:415,130Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Sell StevenOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:252,243Price:--
Filings by filing date
-
Apr 14, 2024 (filed on Apr 17, 2024)Insider Name:Bensley TimothyOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,978Price:$4.95
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Gertsch TimothyOwnership Type:Direct OwnershipSecurities:Options (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:69,189Price:--
-
Apr 14, 2024 (filed on Apr 17, 2024)Insider Name:Gertsch TimothyOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-810Price:$4.95
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Gertsch TimothyOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:42,041Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Venkatachaliah GirishOwnership Type:Direct OwnershipSecurities:Options (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:184,502Price:--
-
Apr 14, 2024 (filed on Apr 17, 2024)Insider Name:Venkatachaliah GirishOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,056Price:$4.95
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Venkatachaliah GirishOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:112,108Price:--
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Shaker BenjaminOwnership Type:Direct OwnershipSecurities:Options (Right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:322,879Price:--
-
Apr 14, 2024 (filed on Apr 17, 2024)Insider Name:Shaker BenjaminOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-5,506Price:$4.95
-
Apr 15, 2024 (filed on Apr 17, 2024)Insider Name:Shaker BenjaminOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:196,189Price:--
News
Biz Brief
Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 6210 E Hwy 290, Suite 450 AUSTIN TX 78723 |
Tel: | N/A |
Website: | https://www.agilonhealth.com |
IR: | See website |
Key People | ||
Steven J. Sell President, Chief Executive Officer, Director | Ravi Sachdev Vice Chairman of the Board | Timothy S. Bensley Chief Financial Officer |
Girish Venkatachaliah Chief Technology Officer | Benjamin Shaker Chief Markets Officer | Veeral Desai Chief Strategy and Development Officer | Karthik Rao Interim Chief Medical Officer |
Business Overview |
agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners' attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon's platform, agilon's long-term physician partnership approach, and agilon's network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital. |
Financial Overview |
For the fiscal year ended 31 December 2023, Agilon Health Inc revenues increased 81% to $4.32B. Net loss before extraordinary items increased from $92M to $195M. Revenues reflect Other operating revenue increase from $3.3M to $9M. Higher net loss reflects Other medical expenses increase of 30% to $238M (expense), Stock-based compensation expense increase from $28.4M to $69.5M (expense). |
Employees: | 1,117 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $1,659M as of Dec 31, 2023 |
Annual revenue (TTM): | $4,316M as of Dec 31, 2023 |
EBITDA (TTM): | -$211.78M as of Dec 31, 2023 |
Net annual income (TTM): | -$195.05M as of Dec 31, 2023 |
Free cash flow (TTM): | -$187.01M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 411,057,065 as of Apr 4, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |